Plasma exchange therapy in COVID-19 patients: ICMR invites institutions to apply for clinical trials

The project is named "Multi-center, Phase II, Open Label, Randomized Controlled Study of Therapeutic Plasma Exchange in COVID-19".

Published On 2020-04-13 08:41 GMT   |   Update On 2020-04-13 10:00 GMT
Advertisement

New Delhi: The Indian Council of Medical Research (ICMR) has sought letters of intent from institutions with necessary equipment and infrastructure to participate in a clinical trial to study safety and efficacy of therapeutic plasma exchange in COVID-19 patients, subsequent to necessary approvals and clearances.

The apex medical research body's invite was uploaded on the ICMR website on Sunday.

The project is named "Multi-center, Phase II, Open Label, Randomized Controlled Study of Therapeutic Plasma Exchange in COVID-19".

Advertisement

The Therapeutic Plasma Exchange (TPE) is an experimental procedure for critically ill COVID-19 patients which, the ICMR said, it does not recommend as a treatment option outside of clinical trials.

READ ALSO: India to explore blood plasma therapy for corona patients

"Institutions interested to collaborate with ICMR on undertaking this trial intervention may express their interest by providing the details through the following link: https://forms.gle/7AaW528DMQbNZsUr9," said the ICMR on its website, adding that hospitals and institutions planning to provide this modality of treatment should do so in a clinical trial with protocols which are cleared by the Institutional Ethics Committee.

The primary objective of the study is to assess the efficacy of TPE in improving the clinical status of COVID-19 patients and to evaluate the safety of treatment with anti SARS-CoV-2 plasma in patients with COVID-19.

The study will include hospitalised COVID-19 patients who are critically ill, fulfil the inclusion and exclusion criteria, and are admitted for care at COVID-19 management facilities in India.

READ ALSO: Clinical trial to assess tpA in COVID-19-related ARDS


Tags:    
Article Source : IANS

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News